Physician profile
Andrew P Schell
NPI 1871723742
$5,095.32
in general payments reported to CMS, 2019-2025
17 companies · $1,203 in 2025
The $1,203 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $319 · 2021: $592 · 2022: $684 · 2023: $507 · 2024: $1,147 · 2025: $1,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,856.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $990.26 | 2019-2025 | |
| Aerin Medical INC. | $876.70 | 2020-2025 | |
| Glaxosmithkline, LLC. | $700.68 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $622.47 | 2020-2025 | Dupixent |
| Optinose US, INC. | $522.99 | 2019-2025 | |
| Medtronic, INC. | $292.09 | 2024-2025 | Propel, Stealthstation S8 Platform, Nuvent |
| Acclarent, INC | $284.03 | 2019-2021 | |
| Stryker Corporation | $261.82 | 2019-2024 | Scopis Ent |
| Intersect Ent, INC. | $191.95 | 2019 | |
| Inspire Medical Systems, INC. | $166.29 | 2021 | |
| Hikma Pharmaceuticals USA | $56.92 | 2024-2025 | Ryaltris |
| Integra Lifesciences Corporation | $37.60 | 2019 | |
| Allergan, INC. | $24.13 | 2022 | |
| Checkpoint Surgical, INC | $19.00 | 2023 | Checkpoint Stimulators |
| Novartis Pharmaceuticals Corporation | $17.91 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $16.31 | 2024 | |
| Kaleo, INC. | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Schell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.